×

WATCH NOW -

Life Sciences Investor Briefing Webcast

Symvan Capital (Fund)

Symvan Technology EIS Fund & SEIS Fund 3

19 Dec 2018 / Tax enhanced research

The funds’ strategy is to invest in EIS and SEIS qualifying companies involved in the development, commercialisation and sale of innovative technologies or services, or use them to gain a competitive advantage.

Why Invest?

Positives

Strategy: Exposure to a portfolio of early start-upor scale-up technology companies.

Issues

Portfolio Risk: Early stage companies carry significant risk. To date Symvan have had only one failure across their portfolios.

The Fund Manager

Positives

Team: Symvan bring a broad range of capital markets experience and a focus on a company’s funding needs throughout its investment period.

Issues

Depth of Staff: The Symvan team is small, though has very experienced advisors and only a few companies to manage.

Nuts & Bolts

  • Regulation: The open funds have Symvan as Fund Manager.
  • Diversification: Exposure to a ‘handful’ of companies – previous closings have had 4-6 investments with those investing across more than one tranche getting up to 11.
  • Valuation: Initially companies will be unquoted. Valuation changes prior to exit mainly through follow on investments, and in line with IPEV guidelines.

Specific Issues

  • Fees: All charged via company except performance fee, though some may be taken in warrants to reduce cash flow strain. Performance fee of 20% of all gains.
  • Investment Process: A life-cycle approach to investment, looking at the plan for the next five years. Focus on deeper rather than wider knowledge of companies and management.

Risks

Target Returns: The target return in both funds is around £2.85 for each £1 invested, which is appropriate for a higher risk product.
Risk Mitigation: The Symvan approach is one of ‘deeper rather than wider’, with a strong focus on management

This report is available on request.

Request a meeting

If you'd like to be introduced to the team at Symvan Capital (Fund), get in touch.

Request a meeting